MUKKA PROTEINS
|
MUKKA PROTEINS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 2.34 | 2.00 | 1.10 | 163.20 | 239.56 |
| CEPS(Rs) | 2.89 | 2.70 | 1.56 | 0.88 | 0.83 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 13.20 | 6.72 | 4.47 | 1,209.53 | 1,028.18 |
| Tax Rate(%) | 15.04 | 27.93 | 28.24 | 28.77 | 31.20 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 7.49 | 7.11 | 6.07 | 3.62 | 4.33 |
| EBIT Margin(%) | 8.00 | 6.80 | 5.93 | 3.89 | 4.90 |
| Pre Tax Margin(%) | 6.21 | 5.44 | 4.67 | 2.56 | 3.59 |
| PAT Margin (%) | 5.28 | 3.92 | 3.35 | 1.82 | 2.47 |
| Cash Profit Margin (%) | 6.16 | 4.90 | 4.46 | 3.21 | 3.33 |
| Performance Ratios | |||||
| ROA(%) | 9.80 | 9.82 | 6.91 | 3.40 | 5.50 |
| ROE(%) | 27.32 | 38.61 | 31.32 | 17.89 | 27.00 |
| ROCE(%) | 19.39 | 24.44 | 18.35 | 11.08 | 16.57 |
| Asset Turnover(x) | 1.86 | 2.50 | 2.06 | 1.86 | 2.22 |
| Sales/Fixed Asset(x) | 10.30 | 9.77 | 6.94 | 6.02 | 7.19 |
| Working Capital/Sales(x) | 4.76 | 19.78 | 61.81 | -40.66 | -49.17 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.10 | 0.10 | 0.14 | 0.17 | 0.14 |
| Receivable days | 38.72 | 26.30 | 25.87 | 25.05 | 21.10 |
| Inventory Days | 84.67 | 59.45 | 74.55 | 80.08 | 68.16 |
| Payable days | 42.92 | 44.27 | 56.82 | 64.49 | 54.51 |
| Valuation Parameters | |||||
| PER(x) | 15.62 | - | - | - | - |
| PCE(x) | 12.63 | - | - | - | - |
| Price/Book(x) | 2.76 | - | - | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 0.96 | 0.21 | 0.24 | 0.27 | 0.26 |
| EV/Core EBITDA(x) | 10.92 | 2.67 | 3.35 | 5.04 | 4.60 |
| EV/EBIT(x) | 11.81 | 3.01 | 3.98 | 6.84 | 5.40 |
| EV/CE(x) | 1.75 | 0.62 | 0.46 | 0.45 | 0.50 |
| M Cap / Sales | 0.79 | - | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 17.22 | 52.77 | 27.60 | 9.94 | 34.36 |
| Core EBITDA Growth(%) | 31.16 | 71.19 | 70.46 | 0.60 | 20.45 |
| EBIT Growth(%) | 36.56 | 80.51 | 94.49 | -12.85 | 16.41 |
| PAT Growth(%) | 56.35 | 84.07 | 134.50 | -18.89 | -0.78 |
| EPS Growth(%) | 16.56 | 82.07 | -99.33 | -31.88 | -7.80 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.91 | 1.72 | 1.76 | 2.39 | 2.51 |
| Current Ratio(x) | 1.57 | 1.15 | 1.05 | 0.95 | 0.95 |
| Quick Ratio(x) | 0.75 | 0.58 | 0.44 | 0.39 | 0.42 |
| Interest Cover(x) | 4.48 | 5.00 | 4.72 | 2.93 | 3.74 |
| Total Debt/Mcap(x) | 0.33 | - | - | - | - |
Compare Financial Ratios of peers of MUKKA PROTEINS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MUKKA PROTEINS | ₹893.4 Cr | -0.6% | -2.1% | -24.2% | Stock Analytics | |
| NESTLE INDIA | ₹237,438.0 Cr | 2.6% | 4.3% | -7.4% | Stock Analytics | |
| VARUN BEVERAGES | ₹162,366.0 Cr | 4.4% | 2.1% | -25.9% | Stock Analytics | |
| BRITANNIA INDUSTRIES | ₹139,258.0 Cr | -1.7% | 3.8% | -0.2% | Stock Analytics | |
| MARICO | ₹94,782.9 Cr | 0.6% | 6.4% | 13.8% | Stock Analytics | |
| JUBILANT FOODWORKS | ₹45,809.8 Cr | 0.9% | 2.5% | 18.9% | Stock Analytics | |
MUKKA PROTEINS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MUKKA PROTEINS | -0.6% |
-2.1% |
-24.2% |
| SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses
